相似文献
1
Room With a View.
Circ Cardiovasc Imaging. 2018 Aug;11(8):e008148. doi: 10.1161/CIRCIMAGING.118.008148.
2
Ang-(1-7) might prevent the development of monocrotaline induced pulmonary arterial hypertension in rats.
Eur Rev Med Pharmacol Sci. 2011 Jan;15(1):1-7.
3
Endothelin-1 driven proliferation of pulmonary arterial smooth muscle cells is c-fos dependent.
Int J Biochem Cell Biol. 2014 Sep;54:137-48. doi: 10.1016/j.biocel.2014.06.020. Epub 2014 Jul 10.
4
Monocrotaline-Induced Pulmonary Hypertension Involves Downregulation of Antiaging Protein Klotho and eNOS Activity.
Hypertension. 2016 Nov;68(5):1255-1263. doi: 10.1161/HYPERTENSIONAHA.116.08184. Epub 2016 Sep 26.
5
PAR-2 inhibition reverses experimental pulmonary hypertension.
Circ Res. 2012 Apr 27;110(9):1179-91. doi: 10.1161/CIRCRESAHA.111.257568. Epub 2012 Mar 29.
6
Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1446-58. doi: 10.1161/ATVBAHA.114.303534. Epub 2014 May 15.
7
Monitoring tumor response to therapy with 18F-FLT PET.
J Nucl Med. 2010 Jun;51(6):841-4. doi: 10.2967/jnumed.109.071217. Epub 2010 May 19.
8
LRP1 promotes synthetic phenotype of pulmonary artery smooth muscle cells in pulmonary hypertension.
Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1604-1616. doi: 10.1016/j.bbadis.2019.03.012. Epub 2019 Mar 22.
9
Noninvasive assessment of cell proliferation in ovarian cancer using [18F] 3'deoxy-3-fluorothymidine positron emission tomography/computed tomography imaging.
Nucl Med Biol. 2011 May;38(4):485-91. doi: 10.1016/j.nucmedbio.2010.12.003. Epub 2011 Mar 3.
10
Pre-clinical validation of orthotopically-implanted pulmonary tumor by imaging with 18F-fluorothymidine-positron emission tomography/computed tomography.
Anticancer Res. 2013 Nov;33(11):4741-9.
本文引用的文献
1
3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography Depicts Heterogeneous Proliferation Pathology in Idiopathic Pulmonary Arterial Hypertension Patient Lung.
Circ Cardiovasc Imaging. 2018 Aug;11(8):e007402. doi: 10.1161/CIRCIMAGING.117.007402.
2
Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients.
Sci Transl Med. 2017 Oct 25;9(413). doi: 10.1126/scitranslmed.aao4583.
3
Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION study.
Lancet Respir Med. 2016 Nov;4(11):894-901. doi: 10.1016/S2213-2600(16)30307-1. Epub 2016 Oct 11.
4
Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1.
Circulation. 2016 Oct 11;134(15):1105-1121. doi: 10.1161/CIRCULATIONAHA.116.023171. Epub 2016 Aug 25.
5
A Selective Transforming Growth Factor-β Ligand Trap Attenuates Pulmonary Hypertension.
Am J Respir Crit Care Med. 2016 Nov 1;194(9):1140-1151. doi: 10.1164/rccm.201510-1955OC.
6
Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.
Circulation. 2016 Mar 29;133(13):1240-8. doi: 10.1161/CIRCULATIONAHA.115.020207. Epub 2016 Feb 12.
7
The Prognostic Value of 18F-FDG Uptake Ratio Between the Right and Left Ventricles in Idiopathic Pulmonary Arterial Hypertension.
Clin Nucl Med. 2015 Nov;40(11):859-63. doi: 10.1097/RLU.0000000000000956.
8
Enhanced [18F]fluorodeoxyglucose accumulation in the right ventricular free wall predicts long-term prognosis of patients with pulmonary hypertension: a preliminary observational study.
Eur Heart J Cardiovasc Imaging. 2014 Jun;15(6):666-72. doi: 10.1093/ehjci/jet276. Epub 2014 Jan 9.
9
PulmoBind, an adrenomedullin-based molecular lung imaging tool.
J Nucl Med. 2013 Oct;54(10):1789-96. doi: 10.2967/jnumed.112.118984. Epub 2013 Aug 15.
10
Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments.
Circulation. 2013 Sep 10;128(11):1214-24. doi: 10.1161/CIRCULATIONAHA.113.004136. Epub 2013 Jul 30.
Zotero 插件